Cargando…
Potential clinical benefits of warfarin in end‐stage cancers: A retrospective analysis
BACKGROUND AND AIMS: Coagulopathy and thromboembolism are common comorbidities in cancer, and anticoagulants, such as warfarin, are needed in specific situations. This study aimed to determine the clinical relevance of prothrombin time (PT) monitoring and the clinical usefulness of warfarin in patie...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871091/ https://www.ncbi.nlm.nih.gov/pubmed/36704424 http://dx.doi.org/10.1002/hsr2.956 |